CLB — Core Laboratories N.V.

Core Laboratories (CLB) Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: $134.5 million, up 3% sequentially but flat year-over-year.
• Service Revenue: $101.1 million, up 5% sequentially and over 2% year-over-year.
• Product Sales: $33.4 million, down slightly from the previous quarter and down 6% year-over-year.
• Operating Income (ex items): $16.6 million, up from $14.5 million in Q2, with an EBIT margin of over 12%.
• Net Income (ex items): $10.2 million, up 15% sequentially but down 14% year-over-year.
• Earnings Per Share (EPS): $0.22 (ex items), up from $0.19 in Q2 but down from $0.25 year-over-year.
• Free Cash Flow: $6.5 million after capital expenditures of $2 million.

2. Strategic Updates and Business Highlights

• Core Lab continues to focus on technology investments to solve client problems and capitalize on global opportunities.
• The Reservoir Description segment saw revenue growth of over 2% due to steady demand for rock and fluid analysis.
• The Production Enhancement segment experienced a 6% revenue increase, driven by demand for completion diagnostic services.
• The company repurchased over 462,000 shares, returning $5 million to shareholders.
• Core Lab is committed to maintaining a lean organization and returning excess free cash to shareholders.

3. Forward Guidance and Outlook

• For Q4 2025, Core projects total revenue between $132 million and $136 million, with operating income expected to range from $14 million to $16.1 million.
• Reservoir Description revenue is projected to be between $88 million and $90 million, while Production Enhancement is expected to range from $44 million to $46 million.
• EPS for Q4 is anticipated to be between $0.18 and $0.22.
• The company maintains a positive long-term outlook, driven by expected growth in global crude oil demand.

4. Bad News, Challenges, or Points of Concern

• Geopolitical Risks: Ongoing international conflicts and sanctions create uncertainty in demand for laboratory services related to crude oil.
• Commodity Price Volatility: Tariffs and fluctuating commodity prices may impact demand and profitability, especially in the U.S. onshore market.
• Flat U.S. Service Revenue: Service revenue in the U.S. remained flat sequentially and decreased nearly 4% year-over-year, indicating potential market saturation or weakness.
• Product Sales Decline: Product sales decreased due to lower completion activity in the U.S. onshore market.

5. Notable Q&A Insights

• Management expressed optimism about future activity levels, particularly in the Middle East, South Atlantic margin, and West Africa, with expectations for increased international investment.
• The recent acquisition of Solintec was discussed, highlighting a unique earn-out structure that aligns incentives between Core Lab and the seller.
• Clients are generally optimistic about higher activity levels in the coming years, particularly in international markets, indicating a potential shift away from reliance on U.S. production growth.

In summary, while Core Laboratories demonstrated solid financial performance in Q3 2025, challenges related to geopolitical risks, commodity price volatility, and a flat U.S. market persist. However, the company remains strategically positioned for growth through technological advancements and international market opportunities.